Search

everythinglearnresearchcommunity

for

Search:↓

A newborn girl had a rare case of salivary gland tissue on her chest, which was safely removed.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

A 23-year-old woman's missed periods were caused by a rare genetic disorder treated with hormone patches.

The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.

Removing hair wrapped around the labia quickly prevents serious tissue damage.

A baby had a unique skin condition with a pale patch and surrounding dark hairs, not linked to other health issues.

The document reports unique growth lines in a child after Stevens-Johnson syndrome, skin reaction from parsnips and sun in a girl, and itchy skin with xanthomas in a boy with Alagille syndrome.

A vibrating anesthetic device significantly reduces pain during mesotherapy for hair loss without complications.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Finasteride exposure in pregnancy causes genital abnormalities in male rats.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Finasteride affects male rat genitalia development, causing abnormalities during specific pregnancy days.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.

Some birth control pills have a higher risk of blood clots than others.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Mice healed without scars as fetuses but developed scars as adults, suggesting scarless healing might be replicated with further research.

The method effectively identifies banned substances in hair loss and skin disease cosmetics.

Fluconazole is an effective antifungal medication with potential side effects and lacks official analytical methods for its determination.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

3D-printed mesoporous scaffolds show promise for personalized drug delivery with controlled release.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Subcutaneous contraceptives can cause side effects like menstrual changes, headaches, weight gain, and pain at the implant site.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.